Global Oncology Molecular Diagnostics Market Trends

Statistics for the 2023 & 2024 Global Oncology Molecular Diagnostics market trends, created by Mordor Intelligence™ Industry Reports. Global Oncology Molecular Diagnostics trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Trends of Global Oncology Molecular Diagnostics Industry

This section covers the major market trends shaping the Oncology Molecular Diagnostics Market according to our research experts:

Polymerase Chain Reaction (PCR) is Anticipated to Observe a Significant Growth

Based on technology, polymerase chain reaction (PCR) is anticipated to witness significant growth. Presently, the polymerase chain reaction (PCR) is the most preferred technology for studying cancer. The major factors contributing to the increasing demand for PCR in oncology molecular diagnostics are greater sensitivity, quantification, ease, precision, and reproducibility, better process quality, fast analysis, and lower risk of contamination. It is a sensitive and rapid technique and is ideal for the detection of lymphoid malignancies. Several manufacturers are engaged in developing PCR-based diagnostic instruments and reagents for the detection of cancer. For instance, in June 2021, the AmoyDx Pan Lung Cancer PCR Panel was launched by Amoy Diagnostics Co. Ltd, Riken Genesis Co. Ltd, and Precision Medicine Asia Co. Ltd. It is approved by the Ministry of Health, Labour and Welfare (MHLW) for marketing and production in Japan. Thus, in view of the factors mentioned above, the market is anticipated to grow significantly over the forecast period.

Incidence Rate of Cancer, By Gender (per thousand), Global, 2020

North America is Anticipated to Observe a Significant Growth in Oncology Molecular Diagnostics Market

Within North America, the United States has held a major share of the market. The major factors contributing to the market growth are the presence of many market players engaged in manufacturing and expanding the portfolio of instruments and reagents for molecular diagnostic testing. The region also witnesses the presence of well-established healthcare diagnostic facilities. As per a 2020 report by the American Cancer Society, several professional associations, including the National Comprehensive Cancer Network (NCCN), the American Association of Clinical Oncology (ASCO), and the College of American Pathologists (CAP), have developed biomarker testing and treatment guidelines. Additionally, the increasing prevalence of cancer in the country contributes to the oncology molecular diagnostics market in the region. As per the 2020 Statistics by the National Cancer Institute (NCI), about 1,806,590 cases of cancer were diagnosed in the United States in 2020, and the number of cancer survivors is projected to reach 2.2 million by 2030. Moreover, as per the NCI, in 2021, the most prevalent cancer type is breast cancer, with 284,200 cases. These factors are leading to an increased demand for oncology molecular testing in the region. Thus, in view of the factors mentioned above, the market is expected to witness significant growth in the region over the forecast period.

Oncology Molecular Diagnostics Market- Growth by Region

Oncology Molecular Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)